65536-08-5

Upstream product

• 67-56-1 methanol 
• 55986-43-1 4-(n-hexadecylamino)benzoic acid 
• 497-19-8 sodium carbonate 
• 112-82-3 hexadecanyl bromide 
• 71134-93-5 4-palmitoylamino-benzoic acid ethyl ester 
• 55791-63-4 ethyl 4-(hexadecylamino)benzoate 
• 112-67-4 n-hexadecanoyl chloride 
• 94-09-7 p-aminoethylbenzoate 

Downstream Products

• 69876-79-5 4-(hexadecylamino)benzoic acid hydrazide 
• 70517-53-2 4-(hexadecylamino)benzyl alcohol 
• 86410-42-6 methyl 4-(hexadecylamino)cyclohexanecarboxylate 
• 70517-91-8 4-(hexadecylamino)-α-(methylsulfinyl)acetophenone 
• 86364-46-7 methyl 4-benzoate 
• 70517-55-4 4-(N-acetyl-N-hexadecylamino)benzyl acetate 
• 70517-56-5 4-(N-acetyl-N-hexadecylamino)benzyl alcohol 
• 86364-47-8 4-(Carboxymethyl-hexadecyl-amino)-benzoic acid 
• 86410-43-7 4-Hexadecylamino-cyclohexanecarboxylic acid 
• 70517-57-6 4-(hexadecylamino)benzyl acetate hydrobromide 
• 65536-06-3 2,3-dihydroxypropyl 4-(hexadecylamino)benzoate 
• 65536-31-4 2,3-diacetoxypropyl 4-(hexadecylamino)benzoate 
• 65536-10-9 2,3-(isopropylidenedioxy)propyl 4-(hexadecylamino)benzoate 
• 65536-23-4 2,3-dihydroxypropyl 4-(N-acetyl-N-hexadecylamino)benzoate 

Relevant academic research and scientific papers

Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogues of cetaben

The syntheses of a series of (aralkylamino)- and (alkylamino)benzoic acids, as well as the corresponding esters and sodium salts, are described. The compounds were evaluated in vivo in rats for serum sterol and triglyceride lowering activity and in vitro

Polysubstituted-alkyl esters of 4-alkylaminobenzoic acids

Polysubstituted-alkyl esters of 4-alkylaminobenzoic acids having hypolipemic activity.